Use of Canadian Marijuana Approved For Tremor Research
https://pixabay.com/en/marijuana-leaves-cannabis-green-3678222/

Use of Canadian Marijuana Approved For Tremor Research

According to medicalexpress.com, the United States government recently approved the import of marijuana extracts from Canada. Though an uncommon occurrence, the US government approved the import for a clinical trial…

Continue Reading Use of Canadian Marijuana Approved For Tremor Research

New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

According to a story from hms.harvard.edu, a recent study is revealing new information about the connection between aging and neurodegenerative disorders, such as Parkinson's disease, dementia, and amyotrophic lateral sclerosis.…

Continue Reading New Information Revealed About The Link Between Neurodegenerative Diseases and Aging
Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease
Skitterphoto / Pixabay

Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease

Two studies have looked into the long-term effects of subthalamic deep brain stimulation as a treatment for Parkinson’s disease. For more detailed information on this topic, you can find the…

Continue Reading Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease

It Looks Like Drug Developers Will Start Using 23andMe Data to Create New Therapies

According to a story from pcmag.com, the pharmaceutical company GlaxoSmithKline (GSK) has recently partnered with 23andMe as part of a four year long agreement that will grant the company exclusive…

Continue Reading It Looks Like Drug Developers Will Start Using 23andMe Data to Create New Therapies
ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
qimono / Pixabay

ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases

Prana Biotechnology has announced that it has begun recruiting healthy volunteers for its Phase I clinical trial of the experimental drug PBT434. The drug is thought to affect processes linked…

Continue Reading ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment
ColiN00B / Pixabay

The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment

The first patient has undergone stem cell transplant treatment in the third cohort of a Phase I clinical study of the experimental treatment ISC-hpNSC for Parkinson’s disease. The full article can…

Continue Reading The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment
Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
source: pixabay.com

Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy

According to a story from businesswire.com, the company Prana Biotechnology Ltd recently announced that it is beginning the recruitment process for its Phase 1 clinical trial of its investigational product…

Continue Reading Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
Anavex Plans to Trial its Treatment For Parkinson’s Disease Dementia, and Researchers are Hopeful that it Could Also Benefit Other Diseases
Source: Pixabay

Anavex Plans to Trial its Treatment For Parkinson’s Disease Dementia, and Researchers are Hopeful that it Could Also Benefit Other Diseases

A drug called Anavex 2-73 being developed to treat Parkinson’s disease dementia is planned to undergo testing in a Phase 2 clinical trial, reports Globe Newswire. Parkinson’s disease is a…

Continue Reading Anavex Plans to Trial its Treatment For Parkinson’s Disease Dementia, and Researchers are Hopeful that it Could Also Benefit Other Diseases